Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for ...

JMP Securities reissued their market perform rating on shares of Stryker (NYSE:SYK – Free Report) in a research note issued ...

Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...

Spencer’s arrival at Eko comes months after the digital health company appointed his former colleague Brent Lang to its board ...

Needham & Company LLC restated their buy rating on shares of Stryker (NYSE:SYK – Free Report) in a report released on Tuesday,Benzinga reports. The firm currently has a $442.00 price objective on the ...

Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired ...

Medical-device maker Stryker on Monday agreed to acquire Inari Medical , which makes devices that treat patients with venous ...

BTIG analyst Ryan Zimmerman maintained a Buy rating on Stryker (SYK – Research Report) yesterday and set a price target of $394.00. The ...

Stryker said it has a definitive agreement to purchase Inari Medical for $80 per share, a big premium that values the deal at ...

U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...

Stryker has agreed to acquire medical technology maker Inari Medical in a deal worth $4.9 billion, the companies said Monday. The medical device maker plans to buy all of Inari's common stock for $80 ...